FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897628840> ?p ?o ?g. }

• W2897628840 endingPage "1675" @default.
• W2897628840 startingPage "1664" @default.
• W2897628840 abstract "It was recently demonstrated that the EWSR1-FLI1 t(11;22)(q24;12) translocation contributes to the hypersensitivity of Ewing sarcoma to PARP inhibitors, prompting clinical evaluation of olaparib in a cohort of heavily pretreated Ewing sarcoma tumors. Unfortunately, olaparib activity was disappointing, suggesting an underappreciated resistance mechanism to PARP inhibition in patients with Ewing sarcoma. We sought to elucidate the resistance factors to PARP inhibitor therapy in Ewing sarcoma and identify a rational drug combination capable of rescuing PARP inhibitor activity.We employed a pair of cell lines derived from the same patient with Ewing sarcoma prior to and following chemotherapy, a panel of Ewing sarcoma cell lines, and several patient-derived xenograft (PDX) and cell line xenograft models.We found olaparib sensitivity was diminished following chemotherapy. The matched cell line pair revealed increased expression of the antiapoptotic protein BCL-2 in the chemotherapy-resistant cells, conferring apoptotic resistance to olaparib. Resistance to olaparib was maintained in this chemotherapy-resistant model in vivo, whereas the addition of the BCL-2/XL inhibitor navitoclax led to tumor growth inhibition. In 2 PDXs, olaparib and navitoclax were minimally effective as monotherapy, yet induced dramatic tumor growth inhibition when dosed in combination. We found that EWS-FLI1 increases BCL-2 expression; however, inhibition of BCL-2 alone by venetoclax is insufficient to sensitize Ewing sarcoma cells to olaparib, revealing a dual necessity for BCL-2 and BCL-XL in Ewing sarcoma survival.These data reveal BCL-2 and BCL-XL act together to drive olaparib resistance in Ewing sarcoma and reveal a novel, rational combination therapy that may be put forward for clinical trial testing." @default.
• W2897628840 created "2018-10-26" @default.
• W2897628840 creator A5000868553 @default.
• W2897628840 creator A5002133095 @default.
• W2897628840 creator A5015077321 @default.
• W2897628840 creator A5017976189 @default.
• W2897628840 creator A5018213660 @default.
• W2897628840 creator A5020741942 @default.
• W2897628840 creator A5022350978 @default.
• W2897628840 creator A5028656040 @default.
• W2897628840 creator A5040751938 @default.
• W2897628840 creator A5049700214 @default.
• W2897628840 creator A5050946845 @default.
• W2897628840 creator A5052806485 @default.
• W2897628840 creator A5054248424 @default.
• W2897628840 creator A5054735839 @default.
• W2897628840 creator A5060699951 @default.
• W2897628840 creator A5088427493 @default.
• W2897628840 date "2019-03-01" @default.
• W2897628840 modified "2023-10-16" @default.
• W2897628840 title "The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity" @default.
• W2897628840 cites W1566328614 @default.
• W2897628840 cites W1566720599 @default.
• W2897628840 cites W1844827255 @default.
• W2897628840 cites W1876426852 @default.
• W2897628840 cites W1971516612 @default.
• W2897628840 cites W1972623885 @default.
• W2897628840 cites W1973195150 @default.
• W2897628840 cites W1981797550 @default.
• W2897628840 cites W1992123147 @default.
• W2897628840 cites W2002936090 @default.
• W2897628840 cites W2007374710 @default.
• W2897628840 cites W2026450884 @default.
• W2897628840 cites W2028982688 @default.
• W2897628840 cites W2031700343 @default.
• W2897628840 cites W2038378765 @default.
• W2897628840 cites W2043398720 @default.
• W2897628840 cites W2062358377 @default.
• W2897628840 cites W2065942206 @default.
• W2897628840 cites W2067275727 @default.
• W2897628840 cites W2073569331 @default.
• W2897628840 cites W2083086786 @default.
• W2897628840 cites W2084884163 @default.
• W2897628840 cites W2088634057 @default.
• W2897628840 cites W2089448176 @default.
• W2897628840 cites W2091134276 @default.
• W2897628840 cites W2093917816 @default.
• W2897628840 cites W2098161852 @default.
• W2897628840 cites W2098737737 @default.
• W2897628840 cites W2103450589 @default.
• W2897628840 cites W2106631796 @default.
• W2897628840 cites W2107959310 @default.
• W2897628840 cites W2110525250 @default.
• W2897628840 cites W2111328917 @default.
• W2897628840 cites W2111518517 @default.
• W2897628840 cites W2116796524 @default.
• W2897628840 cites W2117986690 @default.
• W2897628840 cites W2119180370 @default.
• W2897628840 cites W2119214388 @default.
• W2897628840 cites W2119316461 @default.
• W2897628840 cites W2121155221 @default.
• W2897628840 cites W2122271136 @default.
• W2897628840 cites W2122566852 @default.
• W2897628840 cites W2125789330 @default.
• W2897628840 cites W2126812050 @default.
• W2897628840 cites W2129030243 @default.
• W2897628840 cites W2144847112 @default.
• W2897628840 cites W2160220971 @default.
• W2897628840 cites W2165056381 @default.
• W2897628840 cites W2167516123 @default.
• W2897628840 cites W2167934111 @default.
• W2897628840 cites W2168632005 @default.
• W2897628840 cites W2172242534 @default.
• W2897628840 cites W2172423041 @default.
• W2897628840 cites W2175189903 @default.
• W2897628840 cites W2326963540 @default.
• W2897628840 cites W2341389059 @default.
• W2897628840 cites W2432564198 @default.
• W2897628840 cites W2530695968 @default.
• W2897628840 cites W2580528874 @default.
• W2897628840 cites W2581467944 @default.
• W2897628840 cites W2584413057 @default.
• W2897628840 cites W2767109827 @default.
• W2897628840 cites W2783589193 @default.
• W2897628840 cites W2792813139 @default.
• W2897628840 cites W41026852 @default.
• W2897628840 cites W4379506963 @default.
• W2897628840 cites W2968333193 @default.
• W2897628840 doi "https://doi.org/10.1158/1078-0432.ccr-18-0277" @default.
• W2897628840 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30348635" @default.
• W2897628840 hasPublicationYear "2019" @default.
• W2897628840 type Work @default.
• W2897628840 sameAs 2897628840 @default.
• W2897628840 citedByCount "24" @default.
• W2897628840 countsByYear W28976288402018 @default.
• W2897628840 countsByYear W28976288402019 @default.
• W2897628840 countsByYear W28976288402020 @default.
• W2897628840 countsByYear W28976288402021 @default.

• next